DrugInfoSys

Rabeprazole

Drug #1482

Rabeprazole is a proton pump inhibitor with actions, uses and adverse effcects similar to omeprazole. Rabeprazole (Na) is used in the treatment of peptic ulcer disease and gastroesophageal reflux disease.

Primary Characteristics

Rabeprazole is also known as Rabeprazole (Na).

It is of Synthetic origin and belongs to Sulphinyl Benzimidazole.

Molecular Weight: 359.4 · Non-proprietary name: Rabeprazole (Na).

Molecular structure of Rabeprazole

Pharmacokinetics

None recorded.

Advertisement

Indications

Rabeprazole is primarily indicated in conditions like Gastro-esophageal reflux disease, Peptic ulcer.

Contraindications

Rabeprazole is contraindicated in conditions like Hypersensitivity to the drug.

Dosage

Rabeprazole's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
20 mg20 mgEvery 24hPOFor 4-8 weeks.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

4 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Rabeprazole is known to cause more or less tolerable side effects which are usually transient. These include Abdominal pain, Asthenia , Chest pain, Cough , Diarrhea, Headache, Influenza like syndrome , Nervousness, Pharyngitis, Rhinitis , Sinusitis , UTI , Weight gain.

Warnings / Precautions

Proton pump inhibitors (e.g Rabeprazole) should be given with caution in patients with renal impairment, liver disease, in pregnancy and in breast-feeding. Proton-pump inhibitors may mask symptoms of gastric cancer, particular care is required in those whose symptoms change and in those over 45 years of age; the presence of gastric malignancy should be excluded before treatment.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Rabeprazole should be stored .

Drug Classification

  1. 1.17.1.2Anti-peptic ulcerants

Manufacturers